Asston Pharmaceuticals Announces Key Appointments and EGM in Board Meeting

Asston Pharmaceuticals Ltd held a Board Meeting on 30th March, 2026, where several key decisions were made. The company appointed Mr. Sumit Pawar as the Chief Financial Officer, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The Extraordinary General Meeting (EGM) of the Company is scheduled to be held on 28th April, 2026. The appointments are subject to necessary approvals and compliance requirements.